American Well Corp (AMWL) research
American Well Corp- Sector
- Healthcare
- Industry
- Health Information Services
- Last price
- $12.72
- As of
Kresmion compiles this page from AMWL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
American Well Corp (AMWL): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-04.
As of . Source: SEC EDGAR filings for AMWL. Method and limitations.
Share the AMWL intelligence card
See the full AMWL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AMWL on one page. Preview it with sample data, then open it live with a free account.
Preview the AMWL dossierActive signals for AMWL
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 32.7%, EPS $-0.59 vs $-0.8772 estimate
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 64% of AMWL (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 57% of AMWL (2026Q2)
- highCONSENSUS_SELL
8 tracked funds reduced AMWL this 2026Q1 - institutional consensus
- highCONSENSUS_BUY
8 tracked funds increased AMWL this 2026Q1 - institutional consensus
FREE, NO ACCOUNT
Every signal on AMWL, as it fires
You are seeing 5 of 31 signals recorded on AMWL since 2026-05-16.
The five above landed across 3 days. The other 26 were recorded on 1 other days. 24 of the 31 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in AMWL (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 03044L204 · 2026Q2 | $2.4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 03044L204 · 2026Q2 | $1.3M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 03044L204 · 2026Q2 | $339K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AMWL
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
AMWL against its peers
AMWL's operating margin of -42.2% ranks in the 42nd percentile of 17 Health Information Services sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-31.
| Metric | AMWL | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 249M USD | 115M USD | 74 | 16 |
| Gross margin | n/a | 61.4% | n/a | 11 |
| Operating margin | -42.2% | -12.8% | 42 | 17 |
| Net margin | -38.4% | -15.9% | 42 | 17 |
| Return on equity | -40.6% | -28.4% | 36 | 17 |
| P / E | n/a | 25.2x | n/a | 6 |
Peers (19): OPRX, SY, LFMD, HCAT, CARL, TBRG, NRC, RVRC, CCLD, WEAV, PHR, SOPH, DRIO, VASO, ONMD, BEAT, SDGR, CRVW, BFRG. Left out: HYDTF (no annual filing), RNLXY (period gap), VRHI (no annual filing), DGNOF (no annual filing), RMHI (no annual filing), OHCFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (AMWL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow AMWL on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to AMWL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.